1Watt K, Manzoni P, Cohen-Wolkowiez M, et al. Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole. Curr DrugMetab, 2013, 14 (2):193-202.
7Simitsopoulou M, Peshkova P, Tasina E, et al. Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates. Antimicrob Aents Chemother, 2013, 57 (6) : 2562-2570.
2Martino R, Subira' M, Rovira M, et al. Invasive fungal infections after allogenic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients[J]. Br J Haematol, 2002, 116(2) :475-482.
3Denning DW, Marinus A, Cohen J, et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients, diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group[J]. J Infect, 1998,37(2) :173-180.
4Wingard JR. New approaches to invasive fungal infections in acute leukemia and hematopoietic stem cell transplant patients [J]. Best Pract Res Clin Haematol, 2007,20(1):99-107.
5Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus[J]. Clin Infect Dis,2000, 30(4) :696-709.
6Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunoeompromised patients with cancer and hematopoietie stem cell transplants: an international consensus[J]. Clin Infect Dis, 2002,34(1):7-14.
7Jantunen E, Anttila VJ, Ruutu T. Aspergillus infections in allogeneie stem cell transplant recipients: have we made any progress[J].Bone Marrow Transplant, 2002,30 (12) : 925- 929.
8Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis[J]. N Engl J Med,2002, 347(6) :408-415.
9Pfaller MA, Messer SA, Hollis RJ, et al. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp[J]. Antimicrob Agents Chemother, 2002,46(6) :1723-1727.
10Pfaller MA, Diekema DJ, Messer SA, et al. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001 [J]. J Clin Microbial, 2003,41 (4): 1440-1446.
1LOEFHER J, STEVENS D A. Antifungal drug resistance [J]. Clinieal infeetious diseases, 2003,36 (Suppl I) : 3-41.
2EMRI T, LASZLO M, VIKTORIA T, et al. Echinocandins: production and applications[J]. Applied microbiology and bio- technology,2013(7) :67-3284.
3BOECK L D, FUKUDA D S, ABBOTT B J, et. alDeaeylation of A21978C, an aeidie lipopeptide antibiotic eomplex, by Acti- noplanes utahensis [J]. Journal of antibioties, 1988, 41 (8) ; 1085-1092.
4UEDA S, SHIBATA T, ITO K, et al. Cloning and expres- sion of the FR901379 aeylase gene from Streptomyces sp. no. 6907[J]. Journal of antibioties,2011,64(2) ; 169-175.
5HIMABINDU M, RAVICHANDRA P, ANNAPURNA J. Enhancement of gentamiein production by mutagenesis and non-nutritional stress conditions in Micromonospora echinospo- ra [J]. Preparative biochemistry and bioteehnology, 2007,42 : 1352-1356.
6SHAO Lei, IA Jian, LIU Aijuan, et al. Efficient bioeonver- sion of echinocandin B to its nucleus by overexpression of deacylase genes in different host strains[J]. Applied and en- vironment microbiology,2013,79(4) :1126-1133.
7KREUZMAN A J, HODGES R L, SWARTLING J R, et al. Membrane-associated echinocandin B deacylase of Actinoplanes utahensis : purification, characterization, heterologous cloning and enzymatic deacylation reaction[J]. Journal of industrial microbiol- ogy and biotechnology, 2000,41 ( 3 ) : 173-178.
8SATOSHI U, KAZUNPRI S, NOBUTAKA O, et al. Screening an charaterization of microorganisms with FR901379 acylase activity[J]. Journal of antibiotics, 2009, 63:65-70.
9INOKOSHI J, TAKESHIMA H, TAKESHIMA H, et al. Efficient production of aculeacin A acylase in recombinant Streptomyces strains[J]. Applied biochemistry and biotech- nology, 1993,39:532-536.
10RICHARD H, BALTZ. Streptomyces and Saccharopolyspo- ra hosts for heterologous expression of secondary metabolite gene clusters[J]. Journal of industrial microbiology and bio- technology,2010,37 : 759-777.
